Other reports, however, depicted that CD4+ regulatory T cells seemed to be capable of inhibiting invasive breast cancer development from preinvasive breast cancer by suppressing protumorigenic T helper 2 cell responses [44]. This evidence concerns the gene CD4 and breast carcinoma.